Reviva Pharmaceuticals Holdings, Inc.股价重挫43.70% 市值跌878.28万美元

市场透视2025-06-26

北京时间2025年06月26日21时31分，Reviva Pharmaceuticals Holdings, Inc.（RVPH.us）股票出现异动，股价急速下跌43.70%。截至发稿，该股报0.430美元/股，成交量174.144万股，换手率3.73%，振幅4.14%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-6.43百万美元，每股收益-0.13美元，毛利0.00美元，市盈率-...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2546346297?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-06-26 21:31","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2546346297","market":"us","top_or_hot":-1,"title":"Reviva Pharmaceuticals Holdings, Inc.股价重挫43.70% 市值跌878.28万美元","media":"市场透视","content":"<div>\n<p>北京时间2025年06月26日21时31分，Reviva Pharmaceuticals Holdings, Inc.（RVPH.us）股票出现异动，股价急速下跌43.70%。截至发稿，该股报0.430美元/股，成交量174.144万股，换手率3.73%，振幅4.14%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-6.43百万美元，每股收益-0.13美元，毛利0.00美元，市盈率-...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626213118a4bf497c&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Reviva Pharmaceuticals Holdings, Inc.股价重挫43.70% 市值跌878.28万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nReviva Pharmaceuticals Holdings, Inc.股价重挫43.70% 市值跌878.28万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-06-26 21:31 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626213118a4bf497c&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年06月26日21时31分，Reviva Pharmaceuticals Holdings, Inc.（RVPH.us）股票出现异动，股价急速下跌43.70%。截至发稿，该股报0.430美元/股，成交量174.144万股，换手率3.73%，振幅4.14%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-6.43百万美元，每股收益-0.13美元，毛利0.00美元，市盈率-...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626213118a4bf497c&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RVPH","symbol_name":"Reviva Pharmaceuticals Holdings, Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626213118a4bf497c&s=b","article_id":"2546346297","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626213118a4bf497c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2546346297","pubTimestamp":1750944678,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年06月26日21时31分，Reviva Pharmaceuticals Holdings, Inc.股票出现异动，股价急速下跌43.70%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Vor Biopharma Inc.、Adial Pharmaceuticals, Inc、Plus Therapeutics, Inc.涨幅较大，Adial Pharmaceuticals, Inc、Plus Therapeutics, Inc.、Aspire Biopharma Holdings, Inc.较为活跃，换手率分别为776.08%、169.26%、65.38%，振幅较大的相关个股有Vor Biopharma Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Spyre Therapeutics, Inc.，振幅分别为14.03%、11.86%、10.24%。Reviva Pharmaceuticals Holdings, Inc.公司简介：Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司，致力于发现、开发并寻求商业化治疗药物。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"RVPH":"Reviva Pharmaceuticals Holdings, Inc.","BK4007":"制药"},"translate_title":"Reviva Pharmaceuticals Holdings, Inc. The stock price plummeted 43.70% and the market value fell by US $8.7828 million","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RVPH":1},"content_text":"北京时间2025年06月26日21时31分，Reviva Pharmaceuticals Holdings, Inc.（RVPH.us）股票出现异动，股价急速下跌43.70%。截至发稿，该股报0.430美元/股，成交量174.144万股，换手率3.73%，振幅4.14%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-6.43百万美元，每股收益-0.13美元，毛利0.00美元，市盈率-0.55倍。机构评级方面，在所有5家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Vor Biopharma Inc.、Adial Pharmaceuticals, Inc、Plus Therapeutics, Inc.涨幅较大，Adial Pharmaceuticals, Inc、Plus Therapeutics, Inc.、Aspire Biopharma Holdings, Inc.较为活跃，换手率分别为776.08%、169.26%、65.38%，振幅较大的相关个股有Vor Biopharma Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025(To Pur Com)、Spyre Therapeutics, Inc.，振幅分别为14.03%、11.86%、10.24%。Reviva Pharmaceuticals Holdings, Inc.公司简介：Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司，致力于发现、开发并寻求商业化治疗药物。该公司目前的产品管线主要关注中枢神经系统、炎症和心脏代谢性疾病。该公司利用化学基因组学驱动的技术平台和专有化学方法来开发新药物。公司目前的产品管线中有两个药物候选品，Brilaroxazine（RP5063）旨在治疗多种神经精神疾病，包括精神分裂症、双相情感障碍、抑郁症、注意力缺陷/多动障碍、老年痴呆或阿尔茨海默病的行为和精神症状，以及帕金森病的精神症状，另一个药物候选品是RP1208。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2546346297","isCrawlerRequest":true}